Physiotherapy and Cardiopulmonary Rehabilitation Approaches in SARS-CoV-2 Infection

Abstract

An arising of infectious outbreaks lately December of 2019 has been reported as pneumonia of unknown cause appeared in Wuhan city, China which called SARS-CoV-2. Globally, 12 July 2023, there have been 767.972.961 confirmed cases of COVID-19, including 6.950.655 deaths, reported by WHO. As of 8 July 2023, a total of 13.474.185.140 vaccine doses have been administered. In 2013, the number of people has been died from cardiovascular disease more than 17.3 million and representing an increase from 1990 of 40.8%. Evaluating the effects on cardiopulmonary physiology has an important place among the parameters of the COVID-19 pandemic affecting public health. For this reason, we evaluated physiotherapy and rehabilitation approaches as a for CBRN threats and disaster risk management policies by associating cardiopulmonary physiology with the effects of the COVID-19 (SARS-CoV-2) pandemic